ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

HSCS Heart Test Laboratories Inc

0.0974
0.00 (0.00%)
시간외 단일가
최종 업데이트: 17:49:35
15분 지연
기업명 주식 심볼 시장 주식 타입
Heart Test Laboratories Inc HSCS 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.00 0.00% 0.0974 17:49:35
개장가 저가 고가 종가 전일 종가
0.0974
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
24/04/202422:00GLOBEHeartSciences Announces Grant of Fundamental Patent by the..
03/04/202405:15GLOBEHeartSciences to Present at the LD Micro Invitational XIV..
26/03/202422:00GLOBEHeartSciences Announces Podium Presentation at World..
15/03/202405:15GLOBEHeartSciences Reports Third Quarter Fiscal 2024 Financial..
12/03/202422:00GLOBEHeartSciences’ Announces Peer-Reviewed Publication..
06/03/202423:00GLOBEHeartSciences Announces Canada Patent Grant Covering..
06/03/202406:55EDGAR2Form S-1 - General form for registration of securities under..
27/02/202407:32EDGAR2Form S-8 - Securities to be offered to employees in employee..
26/02/202423:00GLOBEHeartSciences Adds Key Advisor to its Scientific Advisory..
16/02/202406:30EDGAR2Form 8-K - Current report
12/02/202423:00GLOBEHeartSciences Expands its Scientific Advisory Board
01/02/202423:00GLOBEHeartSciences Appoints New Scientific Advisory Board Member
31/01/202423:00EDGAR2Form 8-K - Current report
25/01/202422:59EDGAR2Form 8-K - Current report
18/01/202422:14EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
18/01/202422:11EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
18/01/202422:00GLOBEHeartSciences Announces Results and Adjournment of Annual..
18/01/202421:55EDGAR2Form 8-K - Current report
04/01/202406:15GLOBEHeartSciences Reminds Stockholders to Vote at the Upcoming..
15/12/202306:15GLOBEHeartSciences Reports Second Quarter Fiscal 2024 Financial..
15/12/202306:07EDGAR2Form 8-K - Current report
15/12/202306:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/12/202307:25EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
11/12/202322:30EDGAR2Form SC 13G - Statement of acquisition of beneficial..
09/12/202307:14EDGAR2Form DEF 14A - Other definitive proxy statements
08/12/202307:00EDGAR2Form D/A - Notice of Exempt Offering of Securities: [Amend]
06/12/202323:21EDGAR2Form 8-K - Current report
05/12/202322:00GLOBEHeartSciences Receives FDA Confirmation for 510(k) Clearance..
29/11/202307:26EDGAR2Form PRE 14A - Other preliminary proxy statements
28/11/202306:02EDGAR2Form SC 13G - Statement of acquisition of beneficial..
27/11/202322:30EDGAR2Form 8-K - Current report
21/11/202322:30EDGAR2Form 8-K - Current report
20/11/202322:00GLOBEHeartSciences Announces Closing of License Agreements with..
18/11/202306:51EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
18/11/202306:26EDGAR2Form 8-K - Current report
13/11/202322:45GLOBEHeartSciences’ MyoVista® wavECGTM Selected for Heart..
19/10/202322:00GLOBEHeartSciences Issues Investor Update Highlighting Recent Key..
14/10/202310:36EDGAR2Form S-1/A - General form for registration of securities..
05/10/202306:00EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
26/09/202321:00GLOBEHeartSciences Receives Two New Patent Allowances, Expanding..
25/09/202321:00GLOBEHeartSciences to Participate in the Maxim Group Virtual Tech..
23/09/202305:16EDGAR2Form 8-K - Current report
21/09/202321:00EDGAR2Form 8-K - Current report
21/09/202321:00GLOBEHeartSciences Signs Definitive Agreements with the Icahn..
18/09/202319:09EDGAR2Form S-3 - Registration statement under Securities Act of..
15/09/202305:24EDGAR2Form 8-K - Current report
15/09/202305:15GLOBEHeartSciences Reports First Quarter Fiscal 2024 Financial..
15/09/202305:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/09/202305:15GLOBEHeartSciences to Present at the Gilmartin Group Emerging..
12/09/202305:15GLOBEHeartSciences Named Electrocardiography Advancement..

최근 히스토리

Delayed Upgrade Clock